RS51092B - Escitalopram bromhidrat i postupak za njegovo pripremanje - Google Patents
Escitalopram bromhidrat i postupak za njegovo pripremanjeInfo
- Publication number
- RS51092B RS51092B YUP-2005/0487A YUP20050487A RS51092B RS 51092 B RS51092 B RS 51092B YU P20050487 A YUP20050487 A YU P20050487A RS 51092 B RS51092 B RS 51092B
- Authority
- RS
- Serbia
- Prior art keywords
- preparation
- escitalopram hydrobromide
- escitalopram
- hydrobromide
- crystalline form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Escitalopram bromhidrat, naznačen time, što se nalazi u kristalnom obliku.Prijava sadrži još 2 patentna zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200202005 | 2002-12-23 | ||
PCT/DK2003/000902 WO2004056791A1 (en) | 2002-12-23 | 2003-12-18 | Escitalopram hydrobromide and a method for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
RS20050487A RS20050487A (en) | 2007-06-04 |
RS51092B true RS51092B (sr) | 2010-10-31 |
Family
ID=32668635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2005/0487A RS51092B (sr) | 2002-12-23 | 2003-12-18 | Escitalopram bromhidrat i postupak za njegovo pripremanje |
Country Status (33)
Country | Link |
---|---|
US (1) | US20040167209A1 (sr) |
EP (1) | EP1578738B1 (sr) |
JP (2) | JP4658613B2 (sr) |
KR (1) | KR20050086933A (sr) |
CN (1) | CN100349885C (sr) |
AR (1) | AR042652A1 (sr) |
AT (1) | ATE388947T1 (sr) |
AU (1) | AU2003287919B2 (sr) |
BR (1) | BR0317623A (sr) |
CA (1) | CA2511142A1 (sr) |
CY (1) | CY1107451T1 (sr) |
DE (1) | DE60319739T2 (sr) |
DK (1) | DK1578738T3 (sr) |
EA (1) | EA013116B1 (sr) |
EG (1) | EG24729A (sr) |
ES (1) | ES2298595T3 (sr) |
HK (1) | HK1087708A1 (sr) |
IL (1) | IL169125A0 (sr) |
IS (1) | IS2654B (sr) |
ME (1) | MEP5808A (sr) |
MX (1) | MXPA05005772A (sr) |
MY (1) | MY135468A (sr) |
NO (1) | NO20053595L (sr) |
NZ (1) | NZ540281A (sr) |
PE (1) | PE20040924A1 (sr) |
PL (1) | PL378275A1 (sr) |
PT (1) | PT1578738E (sr) |
RS (1) | RS51092B (sr) |
TW (1) | TW200501943A (sr) |
UA (1) | UA80170C2 (sr) |
UY (1) | UY28148A1 (sr) |
WO (1) | WO2004056791A1 (sr) |
ZA (1) | ZA200504109B (sr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050137255A1 (en) * | 2002-12-23 | 2005-06-23 | H. Lundbeck A/S | Crystalline escitalopram hydrobromide and methods for preparing the same |
CN100349885C (zh) * | 2002-12-23 | 2007-11-21 | H·隆德贝克有限公司 | 依他普仑氢溴酸盐及其制备方法 |
EA200601641A1 (ru) * | 2004-03-05 | 2006-12-29 | Х. Лундбекк А/С | Кристаллическая композиция, содержащая оксалат эсциталопрама |
US7834201B2 (en) | 2005-06-22 | 2010-11-16 | H. Lundbeck A/S | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
TWI347942B (en) | 2005-06-22 | 2011-09-01 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
JP2009511607A (ja) * | 2005-10-14 | 2009-03-19 | ハー・ルンドベック・アクチエゼルスカベット | エスシタロプラムおよびブプロピオンを含有する安定な医薬製剤 |
EP1954257A4 (en) * | 2005-10-14 | 2009-05-20 | Lundbeck & Co As H | METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION |
TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
ES2687756T3 (es) | 2006-07-11 | 2018-10-29 | Mitsubishi Tanabe Pharma Corporation | Sal de un compuesto de morfolina |
WO2008059514A2 (en) * | 2006-07-31 | 2008-05-22 | Cadila Healthcare Limited | Process for preparing escitalopram |
FR3006594A1 (fr) * | 2013-06-11 | 2014-12-12 | Sorin Crm Sas | Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire |
CN108976188B (zh) * | 2017-06-05 | 2022-12-06 | 上海奥博生物医药股份有限公司 | 一种艾司西酞普兰双羟萘酸盐新的制备方法 |
ES2911894T3 (es) * | 2017-10-09 | 2022-05-23 | Hasleton Mark | Nuevas formas de sal y estado sólido de escitalopram |
EP4277661A1 (en) | 2021-01-18 | 2023-11-22 | Anton Frenkel | Pharmaceutical dosage form |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US34712A (en) * | 1862-03-18 | James h | ||
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB8419963D0 (en) * | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
PL199423B1 (pl) * | 1998-10-20 | 2008-09-30 | Lundbeck & Co As H | Sposób wytwarzania citalopramu |
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
ATE355268T1 (de) * | 1999-10-25 | 2006-03-15 | Lundbeck & Co As H | Verfahren zur herstellung von citalopram |
JP2002020379A (ja) * | 2000-05-02 | 2002-01-23 | Sumika Fine Chemicals Co Ltd | シタロプラム臭化水素酸塩の結晶およびその結晶化方法 |
US6977306B2 (en) * | 2000-05-02 | 2005-12-20 | Sumitomo Chemical Company, Limited | Citalopram hydrobromide crystal and method for crystallization thereof |
CA2353693C (en) * | 2000-08-10 | 2003-07-22 | H. Lundbeck A/S | Pharmaceutical composition containing citalopram |
PL198770B1 (pl) * | 2000-12-04 | 2008-07-31 | Westfalia Separator Ag | Sposób wstępnej obróbki surowych olejów i surowych tłuszczów do wytwarzania estrów kwasów tłuszczowych |
CA2445843A1 (en) * | 2001-05-01 | 2002-11-07 | H. Lundbeck A/S | The use of enantiomeric pure escitalopram |
AR034612A1 (es) * | 2001-06-25 | 2004-03-03 | Lundbeck & Co As H | Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram |
CN100349885C (zh) * | 2002-12-23 | 2007-11-21 | H·隆德贝克有限公司 | 依他普仑氢溴酸盐及其制备方法 |
US20050174782A1 (en) * | 2003-03-25 | 2005-08-11 | Chapman Leonard T. | Flashlight |
-
2003
- 2003-12-18 CN CNB2003801063775A patent/CN100349885C/zh not_active Expired - Fee Related
- 2003-12-18 AU AU2003287919A patent/AU2003287919B2/en not_active Ceased
- 2003-12-18 BR BR0317623-1A patent/BR0317623A/pt not_active IP Right Cessation
- 2003-12-18 ME MEP-58/08A patent/MEP5808A/xx unknown
- 2003-12-18 DK DK03779759T patent/DK1578738T3/da active
- 2003-12-18 NZ NZ540281A patent/NZ540281A/en not_active Application Discontinuation
- 2003-12-18 DE DE60319739T patent/DE60319739T2/de not_active Expired - Lifetime
- 2003-12-18 JP JP2004561083A patent/JP4658613B2/ja not_active Expired - Lifetime
- 2003-12-18 EP EP03779759A patent/EP1578738B1/en not_active Expired - Lifetime
- 2003-12-18 ES ES03779759T patent/ES2298595T3/es not_active Expired - Lifetime
- 2003-12-18 EA EA200501046A patent/EA013116B1/ru not_active IP Right Cessation
- 2003-12-18 WO PCT/DK2003/000902 patent/WO2004056791A1/en active IP Right Grant
- 2003-12-18 RS YUP-2005/0487A patent/RS51092B/sr unknown
- 2003-12-18 AT AT03779759T patent/ATE388947T1/de not_active IP Right Cessation
- 2003-12-18 CA CA002511142A patent/CA2511142A1/en not_active Abandoned
- 2003-12-18 KR KR1020057011704A patent/KR20050086933A/ko not_active Application Discontinuation
- 2003-12-18 PL PL378275A patent/PL378275A1/pl not_active Application Discontinuation
- 2003-12-18 MX MXPA05005772A patent/MXPA05005772A/es active IP Right Grant
- 2003-12-18 UA UAA200506077A patent/UA80170C2/uk unknown
- 2003-12-18 PT PT03779759T patent/PT1578738E/pt unknown
- 2003-12-22 MY MYPI20034949A patent/MY135468A/en unknown
- 2003-12-22 TW TW092136380A patent/TW200501943A/zh unknown
- 2003-12-22 AR ARP030104777A patent/AR042652A1/es unknown
- 2003-12-23 UY UY28148A patent/UY28148A1/es not_active Application Discontinuation
- 2003-12-23 US US10/746,913 patent/US20040167209A1/en not_active Abandoned
-
2004
- 2004-01-05 PE PE2004000013A patent/PE20040924A1/es not_active Application Discontinuation
-
2005
- 2005-05-17 IS IS7848A patent/IS2654B/is unknown
- 2005-05-20 ZA ZA200504109A patent/ZA200504109B/en unknown
- 2005-06-09 IL IL169125A patent/IL169125A0/en unknown
- 2005-06-22 EG EGNA2005000345 patent/EG24729A/xx active
- 2005-07-25 NO NO20053595A patent/NO20053595L/no not_active Application Discontinuation
-
2006
- 2006-07-18 HK HK06108012A patent/HK1087708A1/xx not_active IP Right Cessation
-
2008
- 2008-05-02 CY CY20081100470T patent/CY1107451T1/el unknown
-
2010
- 2010-10-20 JP JP2010235287A patent/JP2011037893A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2014041I2 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
MXPA04005435A (es) | Metodo y composiciones para sellar una estructura tubular expandible en un pozo. | |
RS50218B (sr) | Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje leka | |
DE50202328D1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
DE60314124D1 (de) | 2-(2,6-dichlorphenyl)-diarylimidazole | |
MXPA03005222A (es) | Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis. | |
RS51092B (sr) | Escitalopram bromhidrat i postupak za njegovo pripremanje | |
NO20023485D0 (no) | 1,3-disubstituerte pyrrolidiner som alfa-2- adrenoceptorantagonister | |
MXPA03006991A (es) | Derivados de piperidina como antagonistas de neurocinina 1. | |
FI20002903A (fi) | Bittinopeuden määrittäminen | |
MXPA03001783A (es) | N-(3,5-dicloro-2-metoxifenil)-4-metoxi-3- piperazin-1 -il -bencenosulfonamida. | |
ITTO20020157A0 (it) | Macchina depallettizzatrice. | |
DE60315471D1 (de) | 2,5-disubstituierte 3-mercaptopentansaure | |
IL156162A0 (en) | Coniosetin and derivatives thereof, method for producing the same and use thereof. | |
IS7651A (is) | Aðferð til að setja 1,2 tvítengi í 3-oxó-4-aza-sterasambönd | |
AU2003301628A1 (en) | Key unit, method for marking key top, and method for manufacturing key unit using the same | |
AU2003245818A1 (en) | 2,4-dialkyl-branched aldehydes and derivatives produced therefrom | |
NO20044405L (no) | Neurotensinaktive 2,3-diaryl-pyrazolidin derivater | |
AU2002226301A1 (en) | Organic semiconductor, production method therefor and the use thereof | |
DE602004005048D1 (de) | 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo ä3.2.1üoctantartrat-salze | |
ITMI20021328A1 (it) | Nuove piperazine 1,4 - disostituite | |
AU2003266528A1 (en) | Cyclic amine compound, process for producing the same, and use | |
AU2003216893A1 (en) | Phenethylacrylamide, methods for the production thereof and agents containing the same | |
AU2003223100A8 (en) | 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents | |
IT1317859B1 (it) | Metodo per la selezione e la crescita di oociti competenti per losviluppo embrionale. |